555 related articles for article (PubMed ID: 18550603)
1. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
Maruyama Y; Chambers DJ
Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
[TBL] [Abstract][Full Text] [Related]
2. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
[No Abstract] [Full Text] [Related]
3. Ischaemic postconditioning: does cardioplegia influence protection?
Maruyama Y; Chambers DJ
Eur J Cardiothorac Surg; 2012 Sep; 42(3):530-9. PubMed ID: 22345279
[TBL] [Abstract][Full Text] [Related]
4. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution.
von Oppell UO; Du Toit EF; King LM; Owen P; Dunne T; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):405-12. PubMed ID: 1881179
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
Galiñanes M; Chambers DJ; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
[TBL] [Abstract][Full Text] [Related]
7. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
[TBL] [Abstract][Full Text] [Related]
8. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
9. [Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts].
Otani H; Kawasaki H; Ninomiya H; Kido M; Kawaguchi H; Osako M; Kato Y; Imamura H
Nihon Kyobu Geka Gakkai Zasshi; 1997 Jan; 45(1):23-30. PubMed ID: 9028119
[TBL] [Abstract][Full Text] [Related]
10. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
Robinson LA; Harwood DL
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
[TBL] [Abstract][Full Text] [Related]
11. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
[TBL] [Abstract][Full Text] [Related]
12. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution.
Fujii M; Chambers DJ
Eur J Cardiothorac Surg; 2013 Mar; 43(3):619-27. PubMed ID: 22715477
[TBL] [Abstract][Full Text] [Related]
15. Deleterious effect of hypothermia in myocardial protection against cold ischemia: a comparative study in isolated rat hearts.
Lima ML; Fiorelli AI; Vassallo DV; Batista PR; Simoes FV; Fiorim J; Stefanon I; Pinheiro BB; Stolf NA; Gomes OM
Transplant Proc; 2012 Oct; 44(8):2326-32. PubMed ID: 23026585
[TBL] [Abstract][Full Text] [Related]
16. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
Robinson LA; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
[TBL] [Abstract][Full Text] [Related]
17. Protection of the chronic hypoxic immature rat heart during global ischemia.
Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
[TBL] [Abstract][Full Text] [Related]
18. [The experimental study of myocardial protection for warm myocardial ischemia in an isolated rat heart: the effect of a calcium antagonist].
Fukuhiro Y
Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):130-7. PubMed ID: 8717259
[TBL] [Abstract][Full Text] [Related]
19. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial in patients with three-vessel coronary artery disease who underwent myocardial revascularization with extensive use of the internal mammary artery.
Noyez L; van Son JA; van der Werf T; Knape JT; Gimbrère J; van Asten WN; Lacquet LK; Flameng W
J Thorac Cardiovasc Surg; 1993 May; 105(5):854-63. PubMed ID: 8487564
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
